ArticleClinical cancer research : an official journal of the American Association for Cancer Research2022

FDA Approval Summary: Nivolumab in Combination with Ipilimumab for the Treatment of Unresectable Malignant Pleural Mesothelioma.

Erica C Nakajima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.